ADAPT OCULUS is the first study to evaluate a targeted treatment for ocular MG, demonstrating that VYVGART significantly improves disease ...
C-type lectin receptors (CLRs) play central roles in immune recognition, engaging diverse endogenous and exogenous ligands through their C-type lectin-like ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results